![]() |
details | |
![]() |
details | |
![]() |
details | |
![]() |
details | |
![]() |
details |
Date | Description | Mechanisms | ||
---|---|---|---|---|
2020-05-08 |
![]() ![]() |
Share Ownership, Voting Rights, Right To Appoint And Remove Directors | historic | details |
Identifier System | Identifier | Categories | ||
---|---|---|---|---|
LEI | FR5LCKFTG8054YNNRU85 | details |
ABBOTT LABORATORIES (Illinois (US)) | details |
Aptalis Pharma S.r.l. Italy AbbVie GK Japan Allergan International YK Japan Allergan Japan KK Japan Allergan K.K. Japan Allergan NK Japan AbbVie Ltd Korea | details | |
AbbVie SA Belgium Odyssea Pharma SPRL Belgium Syndesi Therapeutics SA Belgium AbbVie Ltd Bermuda AbbVie Biotechnology Ltd Bermuda AbbVie Finance Limited Bermuda AbbVie Global Enterprises Ltd. Bermuda Allergan Development Ventures I | details | |
AbbVie Ltd United Kingdom AbbVie Trustee Company Limited United Kingdom AbbVie UK Holdco Limited United Kingdom Akarna Therapeutics (United Kingdom) | details | |
Allergan Pharma Limited Ireland Allergan Pharmaceuticals International Limited Ireland Allergan Pharmaceuticals Ireland Unlimited Company Ireland Allergan Services International | details | |
AbbVie Spain, S.L. (Spain) | details |
Mark Text | Image | Register | NICE classifications | Registration Date | Expiry Date | ||
---|---|---|---|---|---|---|---|
SYNTHROID DELIVERS PHARMACY |
|
United States Patent and Trademark Office | 35 | 2021-03-30 | details | ||
SYNTHROID DELIVERS PROGRAM |
|
United States Patent and Trademark Office | 35 | 2021-03-30 | details | ||
TRAVERSE |
|
United States Patent and Trademark Office | 42 | 2021-02-09 | details | ||
DREAM. DEFY. DELIVER. |
|
United States Patent and Trademark Office | 44 | 2020-11-17 | details | ||
|
United States Patent and Trademark Office | 44 | 2020-11-17 | details |